HRP960345A2 - Use of ipriflavone to reduce the number of cd8+ cells - Google Patents
Use of ipriflavone to reduce the number of cd8+ cells Download PDFInfo
- Publication number
- HRP960345A2 HRP960345A2 HRP9502198A HRP960345A HRP960345A2 HR P960345 A2 HRP960345 A2 HR P960345A2 HR P9502198 A HRP9502198 A HR P9502198A HR P960345 A HRP960345 A HR P960345A HR P960345 A2 HRP960345 A2 HR P960345A2
- Authority
- HR
- Croatia
- Prior art keywords
- cells
- lymphocytes
- cytotoxic
- ipriflavone
- reaction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP960345A2 true HRP960345A2 (en) | 1998-02-28 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP9502198A HRP960345A2 (en) | 1995-07-21 | 1996-07-18 | Use of ipriflavone to reduce the number of cd8+ cells |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (cs) |
| JP (1) | JP2001503371A (cs) |
| KR (1) | KR19990028933A (cs) |
| CN (1) | CN1191483A (cs) |
| AR (1) | AR002905A1 (cs) |
| AU (1) | AU6367096A (cs) |
| BG (1) | BG102182A (cs) |
| BR (1) | BR9610187A (cs) |
| CA (1) | CA2227421A1 (cs) |
| CZ (1) | CZ2798A3 (cs) |
| EA (1) | EA199800146A1 (cs) |
| EE (1) | EE9800020A (cs) |
| HR (1) | HRP960345A2 (cs) |
| HU (1) | HU9502198D0 (cs) |
| IL (1) | IL122751A0 (cs) |
| MX (1) | MX9800603A (cs) |
| NO (1) | NO980127D0 (cs) |
| PL (1) | PL324460A1 (cs) |
| SK (1) | SK3298A3 (cs) |
| WO (1) | WO1997003664A1 (cs) |
| YU (1) | YU42796A (cs) |
| ZA (1) | ZA966079B (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (it) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/hu unknown
-
1996
- 1996-07-16 PL PL96324460A patent/PL324460A1/xx unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 CN CN96195722A patent/CN1191483A/zh active Pending
- 1996-07-16 JP JP50646497A patent/JP2001503371A/ja active Pending
- 1996-07-16 IL IL12275196A patent/IL122751A0/xx unknown
- 1996-07-16 EA EA199800146A patent/EA199800146A1/ru unknown
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 EE EE9800020A patent/EE9800020A/xx unknown
- 1996-07-16 BR BR9610187A patent/BR9610187A/pt not_active Application Discontinuation
- 1996-07-16 MX MX9800603A patent/MX9800603A/es unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/cs unknown
- 1996-07-16 SK SK32-98A patent/SK3298A3/sk unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/ko not_active Withdrawn
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/xx unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/hr not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/sh unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/es unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/no unknown
- 1998-01-14 BG BG102182A patent/BG102182A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9800603A (es) | 1998-04-30 |
| SK3298A3 (en) | 1998-07-08 |
| AU6367096A (en) | 1997-02-18 |
| CZ2798A3 (cs) | 1998-06-17 |
| NO980127L (no) | 1998-01-12 |
| WO1997003664A1 (en) | 1997-02-06 |
| EE9800020A (et) | 1998-08-17 |
| HU9502198D0 (en) | 1995-09-28 |
| AR002905A1 (es) | 1998-04-29 |
| BG102182A (bg) | 1998-08-31 |
| EP0841915A1 (en) | 1998-05-20 |
| PL324460A1 (en) | 1998-05-25 |
| CN1191483A (zh) | 1998-08-26 |
| CA2227421A1 (en) | 1997-02-06 |
| IL122751A0 (en) | 1998-08-16 |
| JP2001503371A (ja) | 2001-03-13 |
| YU42796A (sh) | 1999-03-04 |
| ZA966079B (en) | 1998-01-19 |
| NO980127D0 (no) | 1998-01-12 |
| BR9610187A (pt) | 1998-07-28 |
| KR19990028933A (ko) | 1999-04-15 |
| WO1997003664A8 (en) | 1999-08-05 |
| EA199800146A1 (ru) | 1998-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2167099B1 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine | |
| KR100479968B1 (ko) | 위장 리파아제 억제제의 용도 | |
| JP2009256384A (ja) | ジアルキルフマレート含有薬剤調合物 | |
| JPWO2004073706A1 (ja) | リバビリン／インターフェロン併用療法の副作用軽減剤 | |
| WO1993024144A1 (en) | PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY | |
| KR100424503B1 (ko) | 암전이억제제 | |
| KR950008767B1 (ko) | 에브셀렌(Ebselen)의 새로운 의약적 용도 | |
| CN118045071A (zh) | 一种治疗缺血性脑卒中疾病的联合用药物及其应用 | |
| WO1993017691A2 (en) | Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease | |
| HRP960345A2 (en) | Use of ipriflavone to reduce the number of cd8+ cells | |
| WO2001049269A1 (en) | Sustained-releasing anthelmintic compositions comprising praziquantel | |
| CN110123813A (zh) | 茄科植物提取的杂环化合物在制备治疗多发性硬化症的药物中的应用及药物 | |
| JPH0686377B2 (ja) | がん転移抑制剤 | |
| WO1999021561A1 (en) | Method for treatment of disorders of attention | |
| US20190381034A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases | |
| US5571800A (en) | Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative | |
| US3666861A (en) | Methods for treating migraine which use 2-(2{40 ,6{40 -dichlorophenyl-amino)-1,3-diszacyclopentene-(2) | |
| MXPA98000603A (en) | Use of ipriflavona to reduce the number of cells c | |
| CA2013443A1 (en) | Pharmaceutical compositions and their use in the treatment of parasitoses | |
| JP2928608B2 (ja) | インスリン依存型糖尿病予防または治療剤 | |
| CA2193838A1 (en) | Disease preventive/remedy | |
| CN114028374A (zh) | 富马酸二甲酯在制备用于保护胰岛β细胞功能的药物中的用途 | |
| CN114028383A (zh) | 一种防治类风湿性关节炎的组合物及应用 | |
| CN119607012A (zh) | 舞茸多糖d组分或其衍生物在制备抗精神分裂症的药物中的应用 | |
| AU672610C (en) | Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| OBST | Application withdrawn |